AXIOM INVESTORS LLC /DE - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
AXIOM INVESTORS LLC /DE ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$2,984,261
+61.4%
50,770
+64.4%
0.03%
+44.4%
Q4 2023$1,848,537
+591.1%
30,881
+339.2%
0.02%
+350.0%
Q3 2023$267,459
-88.6%
7,031
-72.7%
0.00%
-88.6%
Q2 2023$2,349,925
+63.5%
25,795
+18.4%
0.04%
+45.8%
Q1 2023$1,437,598
+9.7%
21,795
-14.0%
0.02%
-7.7%
Q4 2022$1,310,745
-40.0%
25,348
-20.7%
0.03%
-43.5%
Q3 2022$2,184,00031,9750.05%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders